Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma
暂无分享,去创建一个
Jung-Hwan Yoon | Kyung-Suk Suh | Eun Sung Park | Hyun Goo Woo | Bum Joon Park | In-Sun Chu | Jae Hee Cheon | Byeong Gwan Kim | Ju Han Kim | S. Thorgeirsson | H. Woo | Ju-Seog Lee | I. Chu | T. Roskams | Y. Kim | K. Lee | B. Kim | K. Suh | J. Cheon | E. Park | Ju-Seog Lee | Tania Roskams | Snorri S Thorgeirsson | Yoon Jun Kim | Won Kim | N. Yi | Hyo-Suk Lee | Chung Yong Kim | C. Kim | Su Cheol Park | Young Jin Chung | Nam-Joon Yi | Kuhn Uk Lee | Won Kim | Hyo‐suk Lee | B. Park | Y. Chung | J. Yoon | Jung‐Hwan Yoon
[1] Y. Takeda,et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. , 2007, Surgery.
[2] T. Chi,et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[3] Xin Wei Wang,et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. , 2006, Cancer cell.
[4] Hanina Hibshoosh,et al. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. , 2006, Gastroenterology.
[5] H. Huber,et al. A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes , 2006, Oncogene.
[6] K. Reiss,et al. Peroxisome Proliferator–Activated Receptor α Activation Decreases Metastatic Potential of Melanoma Cells In vitro via Down-Regulation of Akt , 2006, Clinical Cancer Research.
[7] A. Tinker,et al. The challenges of gene expression microarrays for the study of human cancer. , 2006, Cancer cell.
[8] Y. Jeng,et al. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. , 2006, Cancer letters.
[9] S. Thorgeirsson,et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.
[10] Masashi Kobayashi,et al. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis. , 2006, Cancer research.
[11] J. Sleeman,et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. , 2005, Cancer research.
[12] M. Abdelrahim,et al. Sp transcription factor family and its role in cancer. , 2005, European journal of cancer.
[13] Frank J. Gonzalez,et al. Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand? , 2005, Journal of Molecular Medicine.
[14] Kathleen F. Kerr,et al. Standardizing global gene expression analysis between laboratories and across platforms , 2005, Nature Methods.
[15] J. Borlak,et al. Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours , 2005, Oncogene.
[16] K. Hanazaki,et al. Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma. , 2005, Hepato-gastroenterology.
[17] K. Hanazaki,et al. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. , 2005, Hepato-gastroenterology.
[18] J. Marrero,et al. Newer markers for hepatocellular carcinoma. , 2004, Gastroenterology.
[19] G. Gores,et al. Diagnosis and staging of hepatocellular carcinoma. , 2004, Gastroenterology.
[20] M. Abdelrahim,et al. Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells , 2004, Cancer Research.
[21] S. Thorgeirsson,et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.
[22] Tsung-Teh Wu,et al. Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer , 2004, Clinical Cancer Research.
[23] S. Loening,et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer , 2004, The Prostate.
[24] D. Xie,et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis , 2004, Oncogene.
[25] C. Pilarsky,et al. CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] G. Michalopoulos,et al. Cyclooxygenase‐2 promotes hepatocellular carcinoma cell growth through AKT activation: Evidence for AKT inhibition in celecoxib‐induced apoptosis , 2003, Hepatology.
[27] H. Asakura,et al. Gross appearance of hepatocellular carcinoma reflects E‐cadherin expression and risk of early recurrence after surgical treatment , 2003, Journal of gastroenterology and hepatology.
[28] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[29] X. Wang,et al. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.
[30] N. Iizuka,et al. MECHANISMS OF DISEASE Mechanisms of disease , 2022 .
[31] M. Kudo,et al. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) , 2003, Journal of Gastroenterology.
[32] I. Petersen,et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.
[33] C. Pilarsky,et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. , 2002, The American journal of pathology.
[34] F. Gonzalez. The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesis , 2002, Molecular and Cellular Endocrinology.
[35] M. Mihara,et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. , 2000, Journal of the American College of Surgeons.
[36] J. Bruix,et al. Prospective Validation of the Cancer of the Liver Italian Program (CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma , 2000, Hepatology.
[37] S. Fan,et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma , 2000, Cancer.
[38] S. Fan,et al. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.
[39] G. Chau,et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. , 2000, Surgery.
[40] J. Rui,et al. Expression of urokinase‐type plasminogen activator, urokinase‐type plasminogen activator receptor, and plasminogen activator inhibitor‐1 and ‐2 in hepatocellular carcinoma , 2000, Pathology international.
[41] J. Rui,et al. Clinical significance of urokinase‐type plasminogen activator activity in hepatocellular carcinoma , 2000, Journal of gastroenterology and hepatology.
[42] G. D'aiuto,et al. Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. , 2000, Cancer research.
[43] B Staels,et al. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. , 1999, Molecular endocrinology.
[44] H. El‐Serag,et al. Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.
[45] H. Hasegawa,et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.
[46] J. Sleeman,et al. CD 24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis , 2005 .
[47] Members of the Complex Trait Consortium. Standardizing global gene expression analysis between laboratories and across platforms , 2005 .
[48] S. Arii,et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. , 2004, Journal of hepatology.
[49] C. Pilarsky,et al. CD 24 Expression Is a New Prognostic Marker in Breast Cancer , 2003 .
[50] 伊藤 卓資. Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma , 2001 .
[51] L. Gold. The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.